ARCHIVES

FDA Ceases Exclusion Of Women From Early Drug Studies

This article is from The Cancer Letter archive.

Vol. 19 No. 19 | May 7, 1993

Download PDF Visit The Full Archive

Related Articles

Patients “Raise A Voice” For Provenge Approval.

April 27, 2007

In Congress: Senate, House Reports List Priorities For NCI

August 8, 1997

New NCAB Weak In Grant Reviews, Confused By Issues

December 10, 1982

Cornell, MSKCC, Rockefeller To collaborate In $160M Basic Biological Research Program.

June 30, 2000

European Agency Recommends Transfusions Over ESAs For Cancer Patients With Longer Life Expectancy.

June 27, 2008

Conferees Agree On $815 Million For NCI In ‘77

July 30, 1976